Connection

Gianluca Campo to Cardiovascular Agents

Back to Details
This is a "connection" page, showing publications Gianluca Campo has written about Cardiovascular Agents.
Gianluca Campo
Connection Strength
0.649
Cardiovascular Agents
  1. Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials. Int J Cardiol. 2017 Oct 01; 244:59-66.
    View in: PubMed
    Score: 0.429
  2. Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial). EuroIntervention. 2018 01 20; 13(13):1561-1564.
    View in: PubMed
    Score: 0.112
  3. Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial. EuroIntervention. 2017 Aug 04; 13(5):e557-e563.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.